Mental Health Clinics in East Liverpool, OH Accepting Medicare
15 Mental Health Clinics found. Showing 1 - 15
 Pathway Counseling Center, Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 16239 Saint Clair Ave, Pathway Counseling Center, Llc, East Liverpool, OH 43920 Phone: 330-383-2961 |
Comprehensive Mental Health Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 321 W 5th St, East Liverpool, OH 43920 Phone: 330-385-8800 |
Aspire Mental Health Llc Community/Behavioral Health Agency Medicare: Medicare Enrolled Practice Location: 236 W 6th St, East Liverpool, OH 43920 Phone: 330-932-1823 Fax: 330-932-1832 |
Psycare Inc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 15549 State Route 170, Suite 10, East Liverpool, OH 43920 Phone: 330-385-1000 Fax: 330-385-3588 |
Robert B. Sylvies, Psy.d, Inc. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 416 Jackson St, East Liverpool, OH 43920 Phone: 330-386-7870 Fax: 330-382-9075 |
Rainbow Counseling Center, Inc. Psychologist - Counseling Medicare: Medicare Enrolled Practice Location: 414 E 5th St, East Liverpool, OH 43920 Phone: 330-386-3844 Fax: 330-386-4129 |
Shining Reflections Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 509 Market St, East Liverpool, OH 43920 Phone: 330-385-7000 Fax: 330-385-2008 |
Insight Clinical Counseling And Wellness Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 45875 Bell School Rd Ste B, East Liverpool, OH 43920 Phone: 234-254-5656 |
Veritas Community Behavioral Health Llc Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 517 Broadway St Ste 500, East Liverpool, OH 43920 Phone: 330-623-7400 Fax: 330-623-7401 |
Cope Treatment Centers In Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 15613 Pineview Dr Ste C, East Liverpool, OH 43920 Phone: 330-932-1594 Fax: 330-368-0067 |
Help Hotline Crisis Center, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 509 Market Street, East Liverpool, OH 43920 Phone: 330-385-7000 Fax: 330-385-2008 |
Second Chances Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 16687 Saint Clair Ave, Suite 202, East Liverpool, OH 43920 Phone: 330-398-1076 |
Psycare Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 15303 State Rout 170, East Liverpool, OH 43920 Phone: 330-385-1000 Fax: 330-385-3588 |
Psycare Inc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 15303 St. Rt 170, East Liverpool, OH 43920 Phone: 330-385-1000 Fax: 330-385-3588 |
Insight Clinical Counseling And Wellness Clinic - Mental Health Medicare: Medicare Enrolled Practice Location: 45875 Bell School Rd Ste B, East Liverpool, OH 43920 Phone: 234-254-5656 Fax: 234-254-5655 |
News Archive
Researchers aim to explore impact of gender and aging on CapZ levels in the heart
Why do women have lower rates of heart failure than men for most of their lives? University of Guelph researchers have uncovered a possible clue - an actin binding protein called "CapZ" that also protects against heart attacks.
Biogen receives additional patent protection for MS drug TECFIDERA
Biogen Idec today announced that the U.S. Patent and Trademark Office has granted U.S. Patent No. 8,399,514, which offers additional protection for TECFIDERA (dimethyl fumarate), the company's oral therapeutic candidate for the treatment of multiple sclerosis.
Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients
A subanalysis of the phase III ALEX study has shown that alectinib 600 mg twice daily is more effective than standard of care crizotinib in Asian patients with anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer (NSCLC), researchers report at the ESMO Asia 2017 Congress.
Polymer drug-eluting and polymer-free drug-coated stents safe and effective for patients with high bleeding risk
The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug-coated stent in patients at high risk of bleeding and treated with one-month dual antiplatelet therapy (DAPT) found that both are clinically safe and effective.
Research on inflammasomes lays foundations for developing new RA treatments
Patients with more or less severe forms of rheumatoid arthritis (RA) may have the same painful symptoms, but does this mean that the cause of their illness is the same? And therefore that they should all receive the same treatment? Scientists at VIB and Ghent University have demonstrated with their research into inflammasomes that RA should be considered as a syndrome rather than a single disease.
› Verified 5 days ago